BLAB — Britannia Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapValue Trap

Annual balance sheet for Britannia Life Sciences, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

	2018 November 30th	2019 November 30th	2020 November 30th	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	3.88	0.254	0.069	1.63	2.6
Net Total Accounts Receivable
Net Total Receivables	0.438	0.074	0.099	1.79	1.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.63	2.46	0.18	3.48	4.22
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.116	0.116	0.078	0.546	0.452
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5.65	3.16	0.257	21.1	23.5
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	2.72	11.7	13.4	8.32	4.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	9.14	13.2	13.5	19.7	16.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-3.49	-10.1	-13.2	1.35	7.02
Total Liabilities & Shareholders' Equity	5.65	3.16	0.257	21.1	23.5
Total Common Shares Outstanding